Home > Category > Chiral Reagent > (5S)-5-[[[(tert-Butyl)dimethylsilyl]oxy]diphenylmethyl]-6,7-dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Tetrafluoroborate

(5S)-5-[[[(tert-Butyl)dimethylsilyl]oxy]diphenylmethyl]-6,7-dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Tetrafluoroborate

Daicel≥98%,99%e.e.

Catalog No：200546-100MG CAS No.：NA MDLNo： Brand:Daicel purity：≥98%,99%e.e. 特性： Purpose:

Share

Size	Availability	Price(USD)
100MG	请咨询	$1350.00

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	(5S)-5-[[[(tert-Butyl)dimethylsilyl]oxy]diphenylmethyl]-6,7-dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Tetrafluoroborate
CAS	NA
Formula	C₃₃H₄₂N₃OSi·BF₄

Related literature

Sorry, there is no relevant literature

Related

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole)

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole)

2409652-68-0 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1,1'-[(1S)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1S)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1R)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1R)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

(S)-2,2'-Bis(diisopropylphosphanyl)-1,1'-binaphthalene

(S)-2,2'-Bis(diisopropylphosphanyl)-1,1'-binaphthalene

History

(5S)-5-[[[(tert-Butyl)dimethylsilyl]oxy]diphenylmethyl]-6,7-dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Tetrafluoroborate

(5S)-5-[[[(tert-Butyl)dimethylsilyl]oxy]diphenylmethyl]-6,7-dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Tetrafluoroborate

NA ≥98%,99%e.e.

Rabeprazole Sulfide

Rabeprazole Sulfide

Risuteganib hydrochloride

Risuteganib hydrochloride

5-(2-Hydroxyethyl)-4-methyl-3-[(2,4,6-trimethylphenyl)methyl]-thiazolium Chloride

5-(2-Hydroxyethyl)-4-methyl-3-[(2,4,6-trimethylphenyl)methyl]-thiazolium Chloride

1472646-52-8 ≥98%,-

HKDC1

TIP5